Atlas Trials

Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection

Clinical trial NCT02835560 · COMPLETED

Trial details

NCT number
NCT02835560
Sponsor
Livzon Pharmaceutical Group Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Eradication Antibiotic
Start date
2013-06-01
Primary completion
2015-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.